DataSheet_1_WASp Deficiency Selectively Affects the TCR Diversity of Different Memory T Cell Subsets in WAS Chimeric Mice.zip by Wenyan Li (255305)

“…Bioinformatic analyses showed that compared with wild type (WT), WAS knock out (KO)-CD4⁺ TEM cells exhibited increased Simpson index and decreased D50 index (P <0.05); The rank abundance curve of KO-CD4⁺ TEM cells was shorter and steeper than that of WT, and the angle of ^qD and q in KO-CD4⁺ TEM cells was lower than that of WT, while these indexes showed few changes between WT and KO chimeric mice in the CD8⁺TCM population. …”

Northern blot analysis of riRNA. by Hiraku Takada (3599702)

“…The level of rRNA markedly decreased in the stationary phase. [C] <i>E</i>. <i>coli</i> BW25113 was grown in M9-glucose medium, and in the middle of exponential phase, total RNA was prepared using Isogen and subjected to Northern blot analysis using a series of Northern probes (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0163057#pone.0163057.t001" target="_blank">Table 1</a>, probes N01 to N10). riRNA was detected using two specific probes, probe-N3 and probe-N4 (for probes see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0163057#pone.0163057.t001" target="_blank">Table 1</a>; and for primers used for amplification of these probes, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0163057#pone.0163057.s005" target="_blank">S2 Table</a>). …”

Supplemental Material for Juurakko et al., 2021 by Collin L. Juurakko (10941459)

“…</p><p></p><p></p><p> </p><p>A list of protein accession identifications for all significantly increased and decreased proteins obtained by MS were assembled and used as inputs for STRING (version 11.0) to predict protein-protein interactions (Franceschini <i>et al.…”

Tryptophan quenching of LtxA by KI. by Angela C. Brown (1343826)

Mean response rate indicating the velocity of illusory movement, Run 1 and Run 2 combined data (N = 12). by Tatjana Seizova-Cajic (80195)

“…The velocity computed this way steadily decreases throughout the vibration period. <i>Triangles</i>: Means were computed only for periods in which movement was perceived (i.e., zeros were excluded) separately for illusory extension (positive sign) and flexion (negative sign). …”

Epileptiform activity induces opposite changes in the RRP and P_rel. by Carlo Natale Giuseppe Giachello (380180)

“…<p>(A,B) Cumulative curves of EPSP amplitudes evoked at 10 Hz at different time-points. The linear part was fitted as described in Methods. …”

Perfusion of substance P (15 μM) had no effect on the amplitude or slope of the fEPSP recorded from the CA1 region of the rat hippocampal slice by Kerrie N Wease (12951)

“…(b) and (c) Pooled time course data showing the lack of effect of substance P on the slope (b) and amplitude (c) of the fEPSP. Points represent mean ± s.e.m., n = 4. Scale bar represents 0.5 mV and 10 ms.…”

Transcriptional response of components of the Cu efflux network and phenotypic consequences of their deletion. by W. Lee Pang (102290)

“…Expression of the metalloregulator <i>VNG1179C</i> does not change, suggesting that it is post-transcriptionally activated. Error bars are s.e.m for n = 5. Points (X) within each expression profile were normalized to the expression value at t = 0 (X₀). …”

PTEN expression in mitochondrial and cytosolic fraction after the excitotoxic stimulus. by Valentina Grande (647515)

“…Data are expressed as mean ± S.E.M., *<i>P</i><0.05, #<i>P</i><0.05, **<i>P</i><0.01 with Two way ANOVA and Bonferroni post hoc test. …”

Effect of ECFCs and astrocytes-ECFCs on 3D GBM migration. by R. Marisol Herrera-Perez (4993793)

The effect of ranibizumab and aflibercept injected intraperitoneally into neonatal mice. by Yusuke Ichiyama (11237783)

“…(F-I) The high magnification images of the whole-mounted retinas show decreased number of branching points, increased area of regressed capillaries (filled arrowheads), and decreased number of proliferating ECs (open arrowheads) in the aflibercept group but not in the ranibizumab groups. …”

G-chart of Diagnosis Dates of Cancer. by Harald Schrem (578639)

“…Cases marked by the letter “B” and a red dot on the lower control limit (LCL) indicate a failed Benneyan test pointing to statistically relevant increases in the diagnostic event rate which should trigger clinical concerns in regard to causation, e.g. by intensified or uncontrolled immunosuppression. …”

Genome-wide expression changes in early wt, <i>Dnmt1^−/−</i> and TKO EBs. by Christine S. Schmidt (107838)

Astrocytes increase the migration GBM cells in a 3D-brain-like model. by R. Marisol Herrera-Perez (4993793)

Robotic-Assisted Median Arcuate Ligament Release With Celiac Artery Lysis and Celiac Ganglion Neurolysis by G. Kimble Jett (6509428)

“…<a href="https://doi.org/10.1016/j.jvs.2008.12.078"><em>J Vasc Surg</em>. 2009;50:124-133.…”

Table_8_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.XLSX by Huiling Zheng (49699)

“…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”

Table_1_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.DOCX by Huiling Zheng (49699)

“…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”

Table_6_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.DOCX by Huiling Zheng (49699)

“…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”

Table_10_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.DOCX by Huiling Zheng (49699)

“…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”

Table_2_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.XLSX by Huiling Zheng (49699)

“…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”